Loading
Latest filing published 24 Apr 2026 for Journey Medical Corp.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Claude Maraoui in Journey Medical Corp. Over a trading history stretching from 21 July 2022 to 22 April 2026, the count stands at 19 filings.
In open-market terms, that means 2 purchases worth €93k on one side and 10 sales worth €875k on the other. On balance, insiders were net sellers of €782k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 6 share grants and 1 option exercise.
The newest entry dates from 24 April 2026: a share grant, in Journey Medical Corp. The clock since the last published purchase (25 March 2024) now reads 943 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations